Nanoviricides (NNVC) Non Operating Interest Expenses (2013 - 2024)

Nanoviricides has disclosed Non Operating Interest Expenses across 12 years of filings, most recently posting $149.0 for Q4 2024.

• In Q4 2024, Non Operating Interest Expenses fell 98.88% year-over-year to $149.0; the TTM figure through Jun 2025 stood at $149.0 (down 99.7% YoY), while the FY2025 annual figure was $149.0, down 99.7% from the prior year.
• Non Operating Interest Expenses came in at $149.0 for Q4 2024 at Nanoviricides, down from $13315.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $44937.0 in Q1 2020 to a low of -$927.0 in Q2 2022.
• Average Non Operating Interest Expenses over 5 years is $15964.7, with a median of $4789.0 recorded in 2022.
• Year-over-year, Non Operating Interest Expenses tumbled 111.68% in 2022 and surged 14064.89% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $37293.0 in 2020, then slumped by 92.95% to $2631.0 in 2021, then plunged by 96.43% to $94.0 in 2022, then surged by 14064.89% to $13315.0 in 2023, then slumped by 98.88% to $149.0 in 2024.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $149.0 in Q4 2024, $13315.0 in Q4 2023, and $36493.0 in Q3 2023.